There is no doubt that all selective IgA-deficient (sIgAD) patients, including those with T1D with positive anti-tTG IgG antibodies, need to be biopsied to fully understand the histological–serological correlation in this subgroup [70]. This evidence concerns the gene CD79A and type 1 diabetes mellitus.